Description: Remdesivir is now available in Pakistan, IVIREM - Remdesivir is authorized by FDA for the treatment of COVID - 19 | Nabiqasim
Remdesivir is authorized for use under an EUA. Only for the treatment of patients with suspected or laboratory-confirmed SARS-CoV-2 infection and severe COVID-19. Severe disease is defined as patients with an oxygen saturation (SpO2) ≤94% . R equiring supplemental oxygen, mechanical ventilation, and/or (ECMO). Remdesivir is authorized for adult or pediatric patients who are admitted to a hospital . F or whom use of an IV agent is clinically appropriate. Remdesivir must be administered intravenously.
Nabiqasim is soon going to launch Remdesivir with the name of IVIREM. It will be available all over Pakistan, which will make it easier for masses to Ger Remdesivir. Now you can Get Remdesivir in Pakistan in a very economical price.
Nabiqasim also offers contract manufacturing services to its domestic and international customers. We’re certified for conformance to ISO standard 9001:2008 in all its operations. The company has an independent Development section, which is focused to develop new and custom formulations.